Once in a Blue Moon Academia (OBMA)

  Between Cosmetic Grooming, Pharmacology and DHFL Haircut: Ambiguities in the Case of Bohem by Piramal Pharma Limited Posted on 25th October, 2025 (GMT 06:16 hrs) ABSTRACT This paper investigates the regulatory and ethical positioning of Bohem, a men’s grooming product line launched by Piramal Pharma Limited (PPL), within the Indian cosmetic–drug regulatory framework. Drawing upon publicly available documents from the Central Drugs Standard Control Organisation (CDSCO), Piramal Pharma’s corporate communications, and state regulatory norms, the study demonstrates that Bohem—while branded under a major pharmaceutical conglomerate—is not a pharmacologically approved medicine. Rather, it is classified as a cosmetic or personal-care product, subject to the relatively lenient provisions of the Cosmetics Rules 2020. The analysis underscores how blurred categorizations between cosmetics and therapeutics enable large corporations to exploit brand trust associated with pharmaceutical c...

  Dynastic Capitalism and Ecological “Externalities”: The Ambani–Piramal Nexus in Post-Liberalization India Posted on 23rd October, 2025 (GMT 07:35 hrs) ABSTRACT This essay investigates how the marital and corporate nexus between the Ambani and Piramal families consolidates dynastic power while enabling ecological, social, and ethical impunity in India’s neoliberal economy. Operating through the Mitakshara coparcenary system, this “nepo-capitalist complex” centralizes vast wealth across Reliance Industries, Piramal Group, and affiliated ventures, while systematically externalizing environmental degradation, resource depletion, and socio-economic costs onto marginalized communities. Through an integrated critique of Ambani’s Reliance’s pollution and cronyism, Campa Cola’s water-intensive operations, Piramal Pharma’s Digwal effluents, Piramal Realty’s climate-vulnerable coastal real estate, Russian oil dealings, Z+ state protection, and the contested Vantara wildlife project, the ess...